Laringotab (Tablets) Instructions for Use
Marketing Authorization Holder
Avva Rus, JSC (Russia)
ATC Code
R02AA20 (Other antiseptics)
Active Substances
Pyridoxine (Rec.INN registered by WHO)
Lysozyme (DCF adopted for use in France)
Dosage Form
| Laringotab | Lozenges 20 mg+10 mg: 10 or 30 pcs. |
Dosage Form, Packaging, and Composition
Lozenges from white to almost white with a brownish tint, round, biconvex; inclusions are allowed.
| 1 tab. | |
| Lysozyme hydrochloride* | 20 mg |
| Pyridoxine hydrochloride | 10 mg |
* lysozyme hydrochloride with a nominal activity of 40000 FIP U/mg
Excipients: hypromellose – 10 mg, povidone K-25 – 7.82 mg, magnesium stearate – 4 mg, sodium saccharin – 0.4 mg, vanilla flavor – 0.1 mg, lactose monohydrate – to obtain a tablet weighing 200 mg.
10 pcs. – blister packs (1) – cardboard packs.
10 pcs. – blister packs (3) – cardboard packs.
Clinical-Pharmacological Group
Topical antiseptic for use in ENT practice and dentistry
Pharmacotherapeutic Group
Drugs for the treatment of throat diseases; antiseptic agents
Pharmacological Action
Combined antiseptic agent.
Lysozyme is an enzyme of protein nature, used as an antiseptic due to its direct effect on gram-positive and gram-negative bacteria, as well as fungi and viruses. It participates in the regulation of local nonspecific immunity.
Pyridoxine has a protective effect on the oral mucosa (exerts an anti-aphthous effect). It does not affect the pharmacodynamic properties of lysozyme.
Indications
Treatment of infectious and inflammatory diseases of the oral mucosa, gums, and larynx: gingivitis; stomatitis; catarrhal phenomena of the upper respiratory tract; aphthous ulcerations; herpetic lesions of the oral mucosa (as part of complex therapy); erosions of the oral mucosa of various etiologies.
ICD codes
| ICD-10 code | Indication |
| B00.2 | Herpetic gingivostomatitis and pharyngotonsillitis |
| J02 | Acute pharyngitis |
| J03 | Acute tonsillitis |
| J04.0 | Acute laryngitis |
| J06.9 | Acute upper respiratory infection, unspecified |
| J31.2 | Chronic pharyngitis |
| J35.0 | Chronic tonsillitis |
| J37.0 | Chronic laryngitis |
| K05 | Gingivitis and periodontal diseases |
| K12 | Stomatitis and related lesions |
| ICD-11 code | Indication |
| 1F00.0 | Infection of skin or mucous membranes caused by herpes simplex virus |
| 1F00.02 | Gingivostomatitis caused by herpes simplex virus |
| CA02.Z | Acute pharyngitis, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| CA05.0 | Acute laryngitis |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
| CA09.2 | Chronic pharyngitis |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| CA0G | Chronic laryngitis or laryngotracheitis |
| DA01.Z | Diseases of the oral mucosa, unspecified |
| DA0B.Z | Gingival diseases, unspecified |
| DA0C.Z | Periodontal diseases, unspecified |
| DA0Z | Diseases or disorders of the orofacial complex, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Use topically in the oral cavity.
Dissolve one lozenge slowly in the mouth.
Administer 3 to 4 times per day.
Adhere to a standard treatment course of 8 days.
Do not exceed the recommended daily frequency.
Discontinue use if symptoms persist beyond the treatment course.
Consult a physician for use beyond the indicated duration.
Adverse Reactions
Possible allergic reactions.
Contraindications
Children under 3 years of age; hypersensitivity to the components of the combination.
Use in Pregnancy and Lactation
Can be used during pregnancy and lactation (breastfeeding).
Special Precautions
In case of an allergic reaction, use should be discontinued.
Drug Interactions
When used concomitantly, the combination enhances the effect of antibiotics, including penicillin, chloramphenicol, nitrofurantoin, enhances the effect of diuretics, and weakens the activity of levodopa.
Isoniazid, penicillamine, pyrazinamide, immunosuppressants, estrogens, and oral contraceptives may increase the need for pyridoxine (antagonistic action against pyridoxine or increased renal excretion).
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Picamilon pills 50mg, 60pcs
Ingavirin capsules 90mg, 10pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Fenotropil pills 100mg, 60pcs
Belosalic, lotion solution for external use spray 100ml
Arbidol, capsules 100mg, 40pcs
Phenibut-Vertex pills 250mg, 20pcs
Mildronate capsules 500mg, 90pcs
Actovegin pills 200mg, 50pcs
Nootropil pills 800mg, 30pcs
Kagocel pills 12mg, 30pcs
Daivobet, ointment, 30g
Cavinton Comfort, dispersible pills 10mg 90pcs
OKI, sachets 80mg 2g, 12pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, ointment, 30g 